Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Other Non-Current Assets (2020 - 2025)

BioAtla (BCAB) has disclosed Other Non-Current Assets for 6 consecutive years, with $163000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other Non-Current Assets changed N/A year-over-year to $163000.0; the TTM value through Dec 2025 reached $163000.0, changed N/A, while the annual FY2025 figure was $163000.0, N/A changed from the prior year.
  • Other Non-Current Assets hit $163000.0 in Q4 2025 for BioAtla, roughly flat from $163000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $163000.0 in Q2 2025 and bottomed at $154000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $155750.0, with a median of $154000.0 recorded in 2021.
  • Year-over-year, Other Non-Current Assets increased 0.65% in 2022 and then fell 0.65% in 2023.
  • BioAtla's Other Non-Current Assets stood at $154000.0 in 2021, then changed by 0.0% to $154000.0 in 2022, then changed by 0.0% to $154000.0 in 2023, then changed by 0.0% to $154000.0 in 2024, then increased by 5.84% to $163000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $163000.0, $163000.0, and $163000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.